Accumulating evidence has verified that CUMS participated in the development of depression following various molecular and cellular mechanisms, and regulated the neurotransmitter content and the cAMP-CREB-BDNF (brain-derived neurotrophic factor) signaling pathway. This evidence concerns the gene CREB1 and major depressive disorder.